10/19/12 Contest Update
Binders of Bears materialized on Wall Street Friday morning and there was no debating their demand for equal profits.
At Friday’s close, the Contest median was especially hard hit but remains up 35.22% YTD (vs. up 43.22% YTD a week ago). In comparison, the Nasdaq Biotech Index was up 34.08% YTD (vs. up 36.16% YTD a week ago), while the Nasdaq Composite Index was up 15.37% YTD (vs. up 16.85% YTD a week ago).
RKRW’s portfolio took another beating this week but its YTD gain of 123.20% still gives it a substantial lead. DONS’ portfolio, up 76.60% YTD, held on to second place by a hair, while GENE’s portfolio, up 76.41% YTD, remained in third place.
At Friday's close, 2 of the 38 Contest portfolios continued in the red, with 21 of the 38 portfolios beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week.
(Foreign stock prices are not converted to US$ in the weekly and YTD Top 5 & Bottom 5 tables, when posted.)
Portfolio adjustments: None.
Enjoy a wonderful weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
10/19/12
Rank Name Profit/Loss
1 RKRW 123,196
2 DONS 76,597
3 GENE 76,409
4 DOUGH 63,727
5 TNSAF 63,232
6 BIOJIM 62,116
7 LJM 61,494
8 BIOMAV 60,001
9 ANON 59,360
10 NP1986 58,700
Week's Top 5 Gainers
Symbol 10/12 10/19 Wk. %chg.
GIVN 14.84 18.15 22.30%
NGSX 0.30 0.36 20.00%
OPXA 0.66 0.77 17.56%
ITMN 7.93 9.25 16.65%
PGNX 2.85 3.25 14.04%
Week's Worst 5 Losers
Symbol 10/12 10/19 Wk. %chg.
ISIS 12.64 9.35 -26.03%
BDSI 6.50 5.64 -13.23%
CRME 0.31 0.27 -12.77%
IDRA 1.00 0.87 -12.62%
ARRY 5.08 4.49 -11.61% |
